Associations between fat content of MRI parameters and biochemical parameters The correlations between changes of abdominal fat content and biochemical parameters are shown in Table 3
Have done 3 doses of first month and have had no negative side effects
That is the deciding variable
One in eight Americans is using, or has used, a GLP-1
It is preventable by starting slow and using appropriate concentrations
There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide sold as Mounjaro, Ozempic, Wegovy and Zepound lower the risk of cardiovascular diseases protect the kidney and the liver, reduce inflammation and pain, prevent addiction and substance abuse, help people with arthritis and those with sleep apnea